Notes / Company Goldline Pharmaceutical Ltd. GOLDLINE BSE 544759 ISIN INE204P01026 Finance - Lending Fundamentals Market cap₹32 cr P/E271.61× ROE0.33% Debt / equity0.01 The timeline — 1 note on Goldline Pharmaceutical Ltd. June 2026 09 Jun 26 · 6:56 PM IST Brief Brief · Earnings · Micro cap Goldline Pharmaceutical's profit jumps 45% to ₹411.71 lacs in FY26 The nano-cap drugmaker's first full-year audited results show profit outpacing revenue growth. Revenue rose 11% to ₹3,119.76 lacs. Verify on exchange BSE filings for GOLDLINE NSE filings for GOLDLINE